Core theme across BIOGEL, ANISOGEL, Jellyclock, ConFluReM, and PeriGO — all coordinator-led projects focused on hydrogel engineering and responsive polymer systems.
DWI LEIBNIZ-INSTITUT FUR INTERAKTIVE MATERIALIEN EV
Leibniz institute engineering responsive hydrogels, soft matter, and bioprinted tissue systems — from molecular design to biomedical translation.
Their core work
DWI is a Leibniz research institute in Aachen specializing in interactive and responsive materials — polymers, hydrogels, and soft matter systems that can sense, adapt, or actuate in response to their environment. Their core work spans from fundamental polymer science to applied biomedical materials, including injectable hydrogels for tissue repair, bioprinting of complex tissue architectures, and supramolecular chemistry for drug delivery and bioimaging. They also provide European-level research infrastructure for soft matter characterization (scattering, spectroscopy, rheology), making them both a research producer and a service provider for the broader materials science community.
What they specialise in
ORGANTRANS (organoid transplantation), BioArchitecture (bioprinting complex tissue architectures), and ANISOGEL (spinal cord repair) demonstrate deep capability in biofabrication.
SUPRABIOTICS (supramolecular protective groups for antibiotics) and ULTIMATE (atomically precise 2D materials via dynamic covalent chemistry) show expertise in designed molecular assembly.
EUSMI provides European-scale infrastructure for spectroscopy, scattering, and imaging of soft matter — DWI contributes its characterization facilities to the community.
EVPRO (extracellular vesicle-loaded hydrogel coatings for implants) and PArtCell (artificial cells for drug screening) signal a move toward biologically functional material systems.
ULTIMATE explores bottom-up synthesis of atomically precise 2D materials for energy and electronics — a departure from their biomedical core.
How they've shifted over time
In the early H2020 period (2015–2018), DWI focused on fundamental responsive material science — self-propelling soft colloids, morphing materials, biomimetic hydrogels, and membrane fluid dynamics, largely through prestigious ERC grants. From 2019 onward, a clear shift toward translational biomedical applications emerged: 3D bioprinting, tissue models, extracellular vesicle coatings for implants, organoid transplantation, and artificial cells for drug screening. The institute has moved from asking "how do we make materials respond?" to "how do we build functional biological structures with them?"
DWI is converging its hydrogel and soft matter expertise toward regenerative medicine and biofabrication — expect future work in organ-on-chip, implant coatings, and advanced tissue models.
How they like to work
DWI leads more often than it follows — 7 of 13 projects as coordinator, including all their ERC grants, which signals strong PI-driven research leadership. Their 77 unique partners across 16 countries show a broad European network, though they are not locked into repeat partnerships. For potential collaborators, this means DWI is comfortable building and managing consortia, but also willing to contribute specialist materials expertise as a partner in larger teams.
DWI has collaborated with 77 distinct partners across 16 countries, reflecting a wide European reach typical of a Leibniz institute with strong ERC funding. Their network spans academic, clinical, and industrial partners, with particular density in Western Europe.
What sets them apart
DWI sits at a rare intersection: they combine deep polymer physics and soft matter expertise with hands-on biomedical translation, all within a single institute. Unlike university labs that specialize narrowly, DWI covers the full chain from molecular design to tissue-scale biofabrication. Their affiliation with RWTH Aachen — one of Europe's top technical universities — and their role in European soft matter infrastructure (EUSMI) gives them both academic credibility and practical access to advanced characterization tools that few partners can match.
Highlights from their portfolio
- ConFluReMLargest single grant (EUR 2.5M ERC Advanced Grant) on controlling fluid resistance at membranes — reflects DWI's top-tier fundamental research capacity.
- BioArchitectureERC Proof of Concept grant for bioprinting complex tissue architectures, directly translating earlier ANISOGEL research into a commercializable direction.
- JellyclockEUR 2.28M ERC grant on light-actuated self-pulsing microgels — a striking example of bioinspired materials that blur the line between chemistry and biology.